'''3,4-Ethylenedioxy-''N''-methylamphetamine''' ('''EDMA''') is an [[entactogen]] [[drug]] of the [[substituted amphetamine|amphetamine class]].<ref name="isbn0-9630096-0-5">{{cite book | author = Ann Shulgin | author2 = Alexander Shulgin | title = Pihkal: A Chemical Love Story | publisher = Transform Press | location = | year = 1991 | pages = | isbn = 0-9630096-0-5 | oclc = | doi = | url = http://isomerdesign.com/PiHKAL/read.php?domain=pk&id=110}}</ref><ref name="pmid1829838">{{cite journal | vauthors = McKenna DJ, Guan XM, Shulgin AT | title = 3,4-Methylenedioxyamphetamine (MDA) analogues exhibit differential effects on synaptosomal release of 3H-dopamine and 3H-5-hydroxytryptamine | journal = Pharmacology, Biochemistry, and Behavior | volume = 38 | issue = 3 | pages = 505–12 |date=March 1991 | pmid = 1829838 | doi = 10.1016/0091-3057(91)90005-M| url = http://linkinghub.elsevier.com/retrieve/pii/0091-3057(91)90005-M}}</ref> It is an [[structural analog|analogue]] of [[3,4-methylenedioxy-N-methylamphetamine|MDMA]] where the [[methylenedioxy]] [[functional group|ring]] has been replaced by an [[ethylenedioxy]] ring.<ref name="isbn0-9630096-0-5"/><ref name="pmid1829838"/> EDMA was first synthesized by [[Alexander Shulgin]].<ref name="isbn0-9630096-0-5"/> In his book ''[[PiHKAL]]'', the dosage is listed as 150–250&nbsp;mg, and the duration listed as 3–5 hours.<ref name="isbn0-9630096-0-5"/> According to Shulgin, EDMA produces a bare threshold consisting of [[paresthesia]], [[nystagmus]], and [[hypnogogic]] [[mental imagery|imagery]], with few to no other effects.<ref name="isbn0-9630096-0-5"/> Scientific research has demonstrated that EDMA acts as a non-[[neurotoxic]] [[serotonin releasing agent]] with moderately diminished [[potency (pharmacology)|potency]] relative to MDMA, and with negligible effects on [[dopamine]] release.<ref name="pmid1829838"/> 
